Private Wealth Management Group, LLC Denali Therapeutics Inc. Transaction History
Private Wealth Management Group, LLC
- $301 Billion
- Q2 2025
A detailed history of Private Wealth Management Group, LLC transactions in Denali Therapeutics Inc. stock. As of the latest transaction made, Private Wealth Management Group, LLC holds 296 shares of DNLI stock, worth $4,132. This represents 0.0% of its overall portfolio holdings.
Number of Shares
296Holding current value
$4,132% of portfolio
0.0%Shares
4 transactions
Others Institutions Holding DNLI
# of Institutions
235Shares Held
127MCall Options Held
37.3KPut Options Held
7.9K-
Black Rock Inc. New York, NY13.2MShares$184 Million0.01% of portfolio
-
Baillie Gifford & CO12MShares$167 Million0.13% of portfolio
-
Vanguard Group Inc Valley Forge, PA11.8MShares$165 Million0.0% of portfolio
-
Wellington Management Group LLP Boston, MA11.4MShares$159 Million0.03% of portfolio
-
Ubs Asset Management Americas Inc Chicago, IL6.77MShares$94.5 Million0.02% of portfolio
About Denali Therapeutics Inc.
- Ticker DNLI
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 134,174,000
- Market Cap $1.87B
- Description
- Denali Therapeutics Inc., a biopharmaceutical company, discovers and develops therapeutic candidates for neurodegenerative diseases in the United States. It offers leucine-rich repeat kinase 2 (LRRK2) inhibitor product candidate, including BIIB122/DNL151, a small molecule inhibitor, which is in phase I and phase Ib clinical trials for the treatm...